Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Long non-coding RNA KCNQ1OT1 promotes ovarian cancer cell malignant characteristics by targeting the miR-140-5p/KLK10
Renjie Duan1, Zhenyu Tao2, Shun Tao3
1School of Preclinical Medicine, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Abstract:
Long non-coding RNAs (lncRNAs) have emerged as key regulatory molecules involved in driving cancer progression. However, the specific functional roles of numerous lncRNAs in ovarian cancer (OC) remain largely underexplored. The present study aimed to elucidate the role and underlying mechanisms of potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1 (KCNQ1OT1) in OC progression. Bioinformatics prediction using the TargetScan and starBase databases revealed that both KCNQ1OT1 and kallikrein-related peptidase 10 (KLK10) harbor complementary binding sites for microRNA (miR)-140-5p. The direct interaction between miR-140-5p and KCNQ1OT1 or KLK10 was experimentally validated using miRNA pull-down assays. Analysis of GEO datasets (GSE66957 and GSE47841), followed by RT-qPCR validation in SKOV3 and IOSE80 cells, revealed that KCNQ1OT1 and KLK10 were markedly upregulated, whereas miR-140-5p was downregulated in OC compared with that in normal ovarian controls. CCK-8 and wound-healing assays demonstrated that silencing KCNQ1OT1 markedly suppressed OC cell proliferation and migration, effects that were reversed by miR-140-5p inhibition. Conversely, inhibition of miR-140-5p enhanced OC cell proliferation and migration, which were abrogated by KLK10 knockdown. Collectively, these findings identified a previously unrecognized regulatory axis in OC, in which KCNQ1OT1 promotes tumor cell proliferation and migration by modulating the miR-140-5p/KLK10 pathway. The present study advances the mechanistic understanding of lncRNA-mediated oncogenesis and provides preliminary evidence supporting a potential role of KCNQ1OT1 in OC progression.
Insights
Long non-coding RNA KCNQ1OT1 promotes ovarian cancer progression by regulating the miR-140-5p/KLK10 pathway. This study reveals a novel regulatory axis, advancing understanding of lncRNA in ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are critical regulators of cancer progression.
- The specific roles of many lncRNAs in ovarian cancer (OC) are not well understood.
- KCNQ1OT1 is a lncRNA implicated in cancer, but its function in OC requires elucidation.
Purpose of the Study:
- To investigate the role and molecular mechanisms of KCNQ1OT1 in ovarian cancer progression.
- To identify potential regulatory pathways involving KCNQ1OT1, microRNAs, and target genes in OC.
- To explore KCNQ1OT1 as a potential therapeutic target in ovarian cancer.
Main Methods:
- Bioinformatic analysis (TargetScan, starBase) to predict interactions.
- Experimental validation of interactions using miRNA pull-down assays.
- Gene expression analysis (RT-qPCR) and functional assays (CCK-8, wound-healing) in OC cell lines.
Main Results:
- KCNQ1OT1 and KLK10 were upregulated, while miR-140-5p was downregulated in OC tissues and cells.
- Silencing KCNQ1OT1 inhibited OC cell proliferation and migration.
- KCNQ1OT1 promoted OC progression by modulating the miR-140-5p/KLK10 axis.
Conclusions:
- KCNQ1OT1 acts as an oncogenic lncRNA in ovarian cancer.
- A novel regulatory axis (KCNQ1OT1/miR-140-5p/KLK10) drives OC cell proliferation and migration.
- KCNQ1OT1 represents a potential therapeutic target for ovarian cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression

